Skip to content
healthcare.dev

Trandolapril

NDC 65862-165, Trandolapril, tablet, from Aurobindo Pharma Limited.

Product NDC
65862-165
Status
Listed
Labeler
Aurobindo Pharma Limited
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA078438
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/65862-165 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TRANDOLAPRIL2 mg/1

Pharmacologic classes

Angiotensin Converting Enzyme Inhibitor [EPC]; Angiotensin-converting Enzyme Inhibitors [MoA]

Package NDCNDC-11Package
65862-165-0165862016501100 TABLET in 1 BOTTLE (65862-165-01)
65862-165-99658620165991000 TABLET in 1 BOTTLE (65862-165-99)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/6f25ed16-e5e9-4170-b4b4-3b460887779e

Use it

Look up 65862-165 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/65862-165 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 65862-165. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.